Locoregional treatment of malignant hepatic tumors with biologic response modifiers

Surgical Oncology Clinics of North America
Akira Yamamoto, Takami Sato

Abstract

Locoregional delivery of biologic response modifiers (BRMs) to hepatic tumors is an appealing approach to increase the dwell time of BMRs, to minimize the systemic toxicity, and to induce local and possibly systemic immune responses against tumor cells. Previous clinical studies using this approach showed some encouraging results. However, a large-scale clinical trial is needed to prove the efficacy of locoregional BMR treatment in primary and metastatic hepatic tumors. Combination of various BRM agents with appropriate treatment modalities might further improve the efficacy of locoregional BMR treatment. Additionally, we need to collect more information regarding the host immune response and change in tumor microenvironment after delivering BMRs to hepatic tumors.

References

Dec 1, 1991·Pharmacology & Therapeutics·H Thomas, F R Balkwill
Mar 1, 1991·Ophthalmology·E S GragoudasM D Spar
Jan 1, 1990·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·N MatsuhashiF Takaku
Jan 1, 1990·Journal of Cancer Research and Clinical Oncology·T OkinoK Ohgaki
Jul 1, 1986·AJR. American Journal of Roentgenology·C H CarrascoS Wallace
May 4, 1988·Journal of the National Cancer Institute·S E Krown
May 1, 1995·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·N J LygidakisE Kyparidou
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·U KeilholzW Hunstein
Jun 4, 1997·Journal of the National Cancer Institute·O MicheauM T Dimanche-Boitrel
Feb 14, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y WadaM Kojiro
Oct 13, 1999·Seminars in Liver Disease·F X BoschJ Borràs
Dec 29, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J M LlovetJ Bruix
Feb 2, 2000·Baillière's Best Practice & Research. Clinical Gastroenterology·N E Kemeny, O T Atiq
Jan 12, 2001·Journal of Clinical Gastroenterology·T YoshidaM Monden
Apr 16, 2002·Seminars in Oncology·Don S Dizon, Nancy E Kemeny
Apr 16, 2002·Seminars in Oncology·Takami Sato
Sep 10, 2002·Journal of Pediatric Hematology/oncology·Sandeep SoniHoward L Kaufman
Jan 4, 2003·Nature Reviews. Immunology·Ian Nicholas Crispe
May 9, 2003·Surgical Oncology Clinics of North America·Iwao IkaiYoshio Yamaoka
Mar 3, 2004·Annals of Surgical Oncology·Elizabeth D FeldmanH Richard Alexander
Apr 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruno SangroJesus Prieto
Aug 20, 2005·Trends in Immunology·David G BowenPatrick Bertolino
Sep 6, 2005·Oncology Reports·Teru KumagiMorikazu Onji
Apr 4, 2006·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·C Y Hao, J F Ji

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Clinics in Plastic Surgery
A Mota, A Deisseroth
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses
N B CressF H Hill
JAMA : the Journal of the American Medical Association
Maria A Lopez-OlivoMaria E Suarez-Almazor
© 2022 Meta ULC. All rights reserved